查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1808878

帕金森氏症深部脑部刺激市场（按产品、最终用途、国家和地区）—2025 年至 2032 年全球产业分析、市场规模、市场份额及预测

Deep Brain Stimulation In Parkinson's Disease Market, By Product, By End-use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格
简介目录

帕金森氏症深部脑部刺激市场规模在 2024 年价值 9.1028 亿美元，2025 年至 2032 年的复合年增长率为 10.30%。

帕金森氏症深部脑部刺激 (DBS) 市场是指专注于透过深部脑部刺激疗法治疗帕金森氏症的设备、技术和服务的全球性产业。 DBS 是透过手术将电极植入大脑特定区域，以发出受控的电脉衝，帮助控制药物无法有效控制的运动症状，例如震颤、僵硬和运动迟缓。该市场包括植入式脉衝产生器 (IPG)、电极、刺激编程软体以及植入后支援服务。

帕金森氏症深部脑部刺激市场—市场动态

神经系统疾病盛行率上升推动市场成长

预计神经系统疾病的日益普及将在未来几年推动帕金森氏症深部脑部刺激市场的发展。神经系统疾病是一类影响自主神经系统、週边神经系统和中枢神经系统的疾病。深部脑部刺激系统用于神经外科手术，向目标区域传递电刺激，目的是改变或调节神经功能，达到可逆、可调节的治疗效果。例如，美国国家组织帕金森基金会估计，2023 年 3 月美国将有近 9 万人被诊断出患有帕金森氏症，比先前估计的每年 6 万例诊断率增加 50%。因此，神经系统疾病的日益流行正在推动帕金森氏症深部脑部刺激市场的成长。

帕金森氏症市场的深部脑部刺激—关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年）全球市场预计年复合成长率约为 10.30%

根据产品细分，预计双通道将在 2025 年占据最大市场份额

根据最终用途细分，医院是 2025 年的主要最终用途

按地区划分，北美是 2025 年的主要收入来源

帕金森氏症深部脑部刺激市场細項分析：

全球帕金森氏症深部脑部刺激市场根据产品、最终用途和地区进行细分。

市场依产品分为两类：单通道和双通道。双通道细分市场将在2025年占据最大份额，因为它在减少患者震颤和改善整体生活品质方面效果显着。双通道深部脑电刺激 (DBS) 设备在向特定脑区输送电刺激方面控制力更强、精度更高，因此深受神经外科医生和患者的欢迎。双通道系统强大的性能和可靠性巩固了其市场领先地位。

根据最终用途，市场分为四大类：医院、门诊手术中心、神经内科诊所和研究中心。到2025年，医院将占据市场主导地位。医院通常配备先进的医疗技术和专业人员，能够为需要深部脑部电刺激（DBS）治疗的患者提供全面的照护。许多患者更倾向于选择医院，因为手术较为复杂，并且需要在整个治疗过程中持续监测和支持。此外，医院通常提供多学科诊疗方案，包括神经科医生、神经外科医生和其他医疗保健专业人员，透过协调一致的护理来改善患者的治疗效果。由于帕金森氏症通常表现为多种症状，需要持续管理，因此医院能够提供有效治疗所需的全面护理。

帕金森氏症深部脑部刺激市场—地理洞察

到2025年，北美深部脑部刺激（DBS）将在帕金森氏症市场占据最大收益份额。该地区的主导地位可归因于多种因素，包括帕金森氏症的高发病率、先进的医疗基础设施以及政府和私人部门在研发方面的大量资金投入。机器人辅助植入和微电极设计的改进等技术进步推动了该地区市场的成长。

预计亚太地区帕金森氏症深部脑部刺激 (DBS) 市场将在预测期内实现最快成长。这一快速增长可归因于帕金森氏症患者病率的上升、医疗保健成本的上涨以及人们对 DBS 治疗的认识的提高。该地区也受益于技术进步和新型 DBS 设备的引入。亚太地区各国政府正积极鼓励 DBS 疗法的应用，并提供优惠政策和研发资金。

帕金森氏症深部脑部刺激市场—竞争格局：

几家大型医疗器材公司透过研发推动DBS市场的创新和市场成长。领先的企业不断改进产品，并透过先进的技术和以患者为中心的解决方案脱颖而出。几家主要企业主导市场，市场整合度适中。然而，新公司和新创公司正在加剧竞争和技术进步，从而改善DBS系统和患者治疗效果。美敦力、波士顿科学和雅培是DBS市场的领导者，拥有丰富的神经刺激设备产品组合和全球影响力。美敦力是最大的DBS製造商之一，提供具有自适应刺激和MRI相容性的系统。创新以及与研究机构的合作使该公司保持了竞争力。另一家主要企业波士顿科学则致力于开发尖端的DBS治疗技术，以满足不同患者的需求。

最新动态：

2024年8月，美敦力公司获得美国食品药物管理局（FDA）批准，可为帕金森氏症和特发性震颤患者实施睡眠中DBS手术。这种创新方法允许患者在清醒或睡眠状态下接受DBS手术，从而提高手术的灵活性和舒适度。

目录

第一章：帕金森氏症深部脑部刺激市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 帕金森氏症深部脑部刺激市场产品片段
    • 帕金森氏症深部脑部刺激市场片段（依最终用途）
    • 帕金森氏症深部脑部刺激市场（按国家/地区）
    • 帕金森氏症深部脑部刺激市场（按地区）
  • 竞争洞察

第三章：帕金森氏症深部脑部刺激的主要市场趋势

  • 帕金森氏症深部脑部刺激市场驱动因素
    • 市场驱动因素的影响分析
  • 帕金森氏症深部脑部刺激市场限制
    • 市场限制的影响分析
  • 帕金森氏症深部脑部刺激的市场机会
  • 帕金森氏症深部脑部刺激市场未来趋势

第四章：帕金森氏症深部脑部刺激产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：帕金森氏症深部脑部刺激市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：巴金森氏症深部脑部刺激市场格局

  • 2024年帕金森氏症深部脑部刺激市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：帕金森氏症深部脑部刺激市场－按产品

  • 概述
    • 按产品细分的市占率分析
    • 单通道
    • 双通道

第 8 章：帕金森氏症深部脑部刺激市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医院
    • 门诊手术中心
    • 神经科诊所
    • 研究中心

第九章：巴金森氏症深部脑部刺激市场－按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美帕金森氏症深部脑部刺激主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品）
    • 北美市场规模及预测（依最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 帕金森氏症深部脑部刺激欧洲主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按产品）
    • 欧洲市场规模及预测（依最终用途）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区帕金森氏症深部脑部刺激主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品）
    • 亚太地区市场规模及预测（依最终用途）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 帕金森氏症深部脑部刺激拉丁美洲主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品）
    • 拉丁美洲市场规模及预测（依最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 帕金森氏症深部脑部刺激的主要製造商在中东和非洲
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依产品）
    • MEA 市场规模及预测（依最终用途）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第十章：帕金森氏症产业深部脑部刺激关键供应商分析

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • Abbott
    • Boston Scientific Corporation
    • Medtronic
    • Others

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5511

Deep Brain Stimulation In Parkinson's Disease Market size was valued at US$ 910.28 Million in 2024, expanding at a CAGR of 10.30% from 2025 to 2032.

Deep Brain Stimulation (DBS) in Parkinson's Disease market refers to the global industry that focuses on devices, technologies, and services for treating Parkinson's disease with deep brain stimulation therapy. DBS is the surgical implantation of electrodes in specific areas of the brain to deliver controlled electrical impulses, which help manage motor symptoms such as tremors, stiffness, and bradykinesia that are not adequately controlled by medication. This market consists of implantable pulse generators (IPGs), electrodes, stimulation programming software, and post-implantation support services.

Deep Brain Stimulation In Parkinson's Disease Market- Market Dynamics

Rising prevalence of neurological disorders fuels market growth

The growing prevalence of neurological disorders is expected to drive the Deep Brain Stimulation In Parkinson's Disease Market in the coming years. Neurological disorders are a diverse group of diseases that affect the autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are used in neurosurgical procedures to deliver electrical stimulation to the target area, with the goal of altering or modulating neural functioning and achieving a reversible, adjustable, and therapeutic effect. For instance, the Parkinson's Foundation, a US-based national organization, estimates that nearly 90,000 people were diagnosed with Parkinson's disease in the United States in March 2023, a 50% increase from the previously estimated rate of 60,000 diagnoses per year. As a result, the growing prevalence of neurological disorders is driving the growth of the Deep Brain Stimulation in Parkinson's Disease market.

Deep Brain Stimulation In Parkinson's Disease Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.30% over the forecast period (2025-2032)

Based on Product segmentation, Dual-channel is predicted to show maximum market share in the year 2025

Based on End-use segmentation, hospital is the leading End-use in 2025

On the basis of region, North America is the leading revenue generator in 2025

Deep Brain Stimulation In Parkinson's Disease Market- Segmentation Analysis:

The Global Deep Brain Stimulation In Parkinson's Disease Market is segmented on the basis of Product, End-use, and Region.

The market is divided into two categories based on Product: Single-channel, and Dual-channel. The dual-channel segment will account for the largest share in 2025 due to its superior effectiveness in reducing patient tremors and improving overall quality of life. Dual-channel DBS devices provide greater control and precision in delivering electrical stimulation to specific brain regions, making them popular among neurosurgeons and patients alike. Dual-channel systems' robust performance and reliability have cemented their market leadership.

The market is divided into four categories based on End-use: Hospitals, Ambulatory Surgical Centers, Neurology Clinics, and Research Centers. The hospital segment will dominate the market in 2025. Hospitals are frequently equipped with advanced medical technology and specialized personnel, allowing them to provide comprehensive care to patients requiring DBS therapy. Many patients prefer hospitals because of the procedure's complexity and the need for continuous monitoring and support throughout the treatment process. Furthermore, hospitals typically provide a multidisciplinary approach that includes neurologists, neurosurgeons, and other healthcare professionals, improving patient outcomes through coordinated care. Because Parkinson's disease frequently presents with a variety of symptoms that necessitate ongoing management, hospitals are well-positioned to provide the comprehensive care required for effective treatment.

Deep Brain Stimulation In Parkinson's Disease Market- Geographical Insights

North America Deep Brain Stimulation will have the largest revenue share in the Parkinson's disease market in 2025. The region's dominance can be attributed to a variety of factors, including a high prevalence of Parkinson's disease, advanced healthcare infrastructure, and substantial government and private funding for research and development. Technological advancements, such as robot-assisted implantation and improved microelectrode designs, have boosted market growth in this region.

The Asia Pacific Deep Brain Stimulation In Parkinson's Disease Market is expected to grow the fastest over the forecast period. This rapid growth can be attributed to the rising prevalence of Parkinson's disease, rising healthcare costs, and increased awareness of DBS treatment. The region is also benefiting from technological advancements and the introduction of new DBS devices. Governments in the Asia Pacific region are actively encouraging the use of DBS therapy by providing favorable policies and funding for R&D.

Deep Brain Stimulation In Parkinson's Disease Market- Competitive Landscape:

Several major medical device companies drive innovation and market growth in the DBS market through research and development. Leading players improve their products and differentiate themselves with advanced technologies and patient-centric solutions. Several major players dominate the market, which is moderately consolidated. However, new companies and startups are increasing competition and technological advancements, improving DBS systems and patient outcomes. Medtronic, Boston Scientific, and Abbott are DBS market leaders with extensive neurostimulation device portfolios and global presence. One of the largest DBS manufacturers, Medtronic, offers systems with adaptive stimulation and MRI compatibility. Innovation and collaboration with research institutions have kept the company competitive. Boston Scientific, another major player, develops cutting-edge DBS therapy technologies to meet diverse patient needs.

Recent Developments:

In August 2024, Medtronic plc has received FDA approval for Asleep DBS surgery for Parkinson's and essential tremor patients. This novel approach allows patients to have DBS surgery while awake or asleep, increasing flexibility and comfort.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • Others

GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Single-channel
  • Dual-channel

GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Neurology Clinics
  • Research Centers

GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Deep Brain Stimulation In Parkinson's Disease Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Deep Brain Stimulation In Parkinson's Disease Market Snippet by Product
    • 2.1.2. Deep Brain Stimulation In Parkinson's Disease Market Snippet by End-use
    • 2.1.3. Deep Brain Stimulation In Parkinson's Disease Market Snippet by Country
    • 2.1.4. Deep Brain Stimulation In Parkinson's Disease Market Snippet by Region
  • 2.2. Competitive Insights

3. Deep Brain Stimulation In Parkinson's Disease Key Market Trends

  • 3.1. Deep Brain Stimulation In Parkinson's Disease Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Deep Brain Stimulation In Parkinson's Disease Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Deep Brain Stimulation In Parkinson's Disease Market Opportunities
  • 3.4. Deep Brain Stimulation In Parkinson's Disease Market Future Trends

4. Deep Brain Stimulation In Parkinson's Disease Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Deep Brain Stimulation In Parkinson's Disease Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Deep Brain Stimulation In Parkinson's Disease Market Landscape

  • 6.1. Deep Brain Stimulation In Parkinson's Disease Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Deep Brain Stimulation In Parkinson's Disease Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Single-channel
    • 7.1.3. Dual-channel

8. Deep Brain Stimulation In Parkinson's Disease Market - By End-use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End-use, 2024 & 2032 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Ambulatory Surgical Centers
    • 8.1.4. Neurology Clinics
    • 8.1.5. Research Centers

9. Deep Brain Stimulation In Parkinson's Disease Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Deep Brain Stimulation In Parkinson's Disease Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Deep Brain Stimulation In Parkinson's Disease Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.7. UK
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.7.4. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.8. France
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.8.4. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.9. Italy
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.9.4. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.10. Spain
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.10.4. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.11. The Netherlands
      • 9.3.11.1. Overview
      • 9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.11.4. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Overview
      • 9.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.12.4. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.13. Russia
      • 9.3.13.1. Overview
      • 9.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.13.4. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Deep Brain Stimulation In Parkinson's Disease Key Manufacturers in Asia Pacific
    • 9.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.4.5. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.6. China
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.6.4. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.7.4. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.11. Indonesia
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.12. Thailand
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.5. Latin America (LATAM)
    • 9.5.1. Overview
    • 9.5.2. Deep Brain Stimulation In Parkinson's Disease Key Manufacturers in Latin America
    • 9.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.5.5. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa (MEA)
    • 9.6.1. Overview
    • 9.6.2. Deep Brain Stimulation In Parkinson's Disease Key Manufacturers in Middle East and Africa
    • 9.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.6.5. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.7. UAE
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.7.4. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Deep Brain Stimulation In Parkinson's Disease Industry

  • 10.1. Competitive Benchmarking
    • 10.1.1. Competitive Dashboard
    • 10.1.2. Competitive Positioning
  • 10.2. Company Profiles
    • 10.2.1. Abbott
    • 10.2.2. Boston Scientific Corporation
    • 10.2.3. Medtronic
    • 10.2.4. Others

11. 360 Degree AnalystView

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us